SCHEMBL250442

SCHEMBL250442

CN(C)C1(c2cccs2)CCC(N)CC1.COc1ccc(Br)cc1CCNC(=O)CCCC(=O)O

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
ALDH1A1 P00352 2/20 0.42
GAA P10253 2/20 0.42
KDM4E B2RXH2 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 2/20 0.41
FFAR4 Q5NUL3 1/20 0.39
LMNA P02545 3/20 0.37
TSHR P16473 2/20 0.37
RAB9A P51151 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.36
KCNA3 P22001 2/20 0.35
PKM P14618 1/20 0.35
MC4R P32245 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL250561 0.86 HDAC3 (0.39) MEN1KMT2ALMNATSHR
SCHEMBL249994 0.80 NPC1 (0.45) MEN1KMT2AGAAKDM4EMAPT
SCHEMBL4083314 0.78 KDM4E (0.53) MEN1KMT2AALDH1A1GAAKDM4E
SCHEMBL248648 0.75 NPC1 (0.38) KMT2AGAALMNARAB9A
SCHEMBL4075703 0.74 SMN1; SMN2 (0.55) MEN1KMT2AALDH1A1GAAKDM4E
SCHEMBL249977 0.74 SMN1; SMN2 (0.46) KMT2AALDH1A1MAPTRAB9ATP53
SCHEMBL251283 0.73 OPRM1 (0.44) ALDH1A1GAARAB9A
SCHEMBL4074080 0.73 OPRM1 (0.51) RAB9A
SCHEMBL250033 0.72 OPRL1 (0.42) GAAMAPTRAB9A
SCHEMBL207653 0.72 OPRM1 (0.43) RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed